Clinical Trial Update: Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating varying injection schedules of TDENV-PIV dengue vaccine with AS03B adjuvant versus placebo in healthy adults; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• AS03B adjuvant (AS03B)
• TDENV PIV

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Dengue | Phase 1, Phase 2 | Status: COMPLETED